These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20550062)

  • 41. β-adrenergic receptor signalling and its functional consequences in the diseased heart.
    Najafi A; Sequeira V; Kuster DW; van der Velden J
    Eur J Clin Invest; 2016 Apr; 46(4):362-74. PubMed ID: 26842371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spatial control of the βAR system in heart failure: the transverse tubule and beyond.
    Gorelik J; Wright PT; Lyon AR; Harding SE
    Cardiovasc Res; 2013 May; 98(2):216-24. PubMed ID: 23345264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene interventions in the beta-adrenergic system for treating heart failure.
    Parsa CJ; Koch WJ
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):259-67. PubMed ID: 12973703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-adrenergic stimulation and myocardial function in the failing heart.
    El-Armouche A; Eschenhagen T
    Heart Fail Rev; 2009 Dec; 14(4):225-41. PubMed ID: 19110970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Boosting cardiac contractility with genes.
    Williams RS
    N Engl J Med; 1995 Mar; 332(12):817-8. PubMed ID: 7862189
    [No Abstract]   [Full Text] [Related]  

  • 46. Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.
    Ghigo A; Morello F; Perino A; Damilano F; Hirsch E
    Curr Heart Fail Rep; 2011 Sep; 8(3):168-75. PubMed ID: 21519914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in myocardial and vascular receptors in heart failure.
    Bristow MR
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):61A-71A. PubMed ID: 8397233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Molecular mechanisms of congestive heart failure].
    Shiojima I; Komuro I
    Nihon Rinsho; 2006 May; 64(5):826-31. PubMed ID: 16689360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the β-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside.
    Rengo G; Perrone-Filardi P; Femminella GD; Liccardo D; Zincarelli C; de Lucia C; Pagano G; Marsico F; Lymperopoulos A; Leosco D
    Circ Heart Fail; 2012 May; 5(3):385-91. PubMed ID: 22589366
    [No Abstract]   [Full Text] [Related]  

  • 50. Role of phosphoinositide 3-kinase in cardiac function and heart failure.
    Naga Prasad SV; Perrino C; Rockman HA
    Trends Cardiovasc Med; 2003 Jul; 13(5):206-12. PubMed ID: 12837584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of adrenergic receptor polymorphisms in heart failure.
    Biolo A; Rosa AS; Mazzotti NG; Martins S; Belló-Klein A; Rohde LE; Clausell N
    Braz J Med Biol Res; 2006 Oct; 39(10):1281-90. PubMed ID: 17053838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction.
    Wasilewski MA; Grisanti LA; Song J; Carter RL; Repas AA; Myers VD; Gao E; Koch WJ; Cheung JY; Feldman AM; Tilley DG
    Clin Sci (Lond); 2016 Nov; 130(22):2017-2027. PubMed ID: 27589993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene transfer to spark a failing heart.
    Seachrist L
    Science; 1994 Apr; 264(5158):507-8. PubMed ID: 8160010
    [No Abstract]   [Full Text] [Related]  

  • 54. Adrenergic and serotoninergic regulation of myocardial contractility in patients with various morphofunctional changes in the heart resulting from chronic heart failure.
    Kirillova VV; Dzhordzhikiya RK; Nigmatullina RR
    Bull Exp Biol Med; 2007 Oct; 144(4):501-3. PubMed ID: 18642697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets.
    Iaccarino G; Koch WJ
    Assay Drug Dev Technol; 2003 Apr; 1(2):347-55. PubMed ID: 15090200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proliferative signaling and disease progression in heart failure.
    Katz AM
    Circ J; 2002 Mar; 66(3):225-31. PubMed ID: 11922268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of G-proteins in transduction of the beta-adrenergic response in heart failure.
    Ransnäs LA
    Heart Vessels Suppl; 1991; 6():3-5. PubMed ID: 1668172
    [No Abstract]   [Full Text] [Related]  

  • 58. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components.
    Maurice JP; Koch WJ
    Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and phenotypic targeting of β-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1):5-9. PubMed ID: 27520660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. beta-adrenergic receptor signaling: an acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models.
    Vatner SF; Vatner DE; Homcy CJ
    Circ Res; 2000 Mar; 86(5):502-6. PubMed ID: 10720410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.